Sagent Pharmaceuticals has announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80mg per 8mL multi-dose vials and 160mg per 16mL multi-dose vials). The product was distributed by Sagent Pharmaceutical, and the company has initiated a voluntary recall.
The Docetaxel Injection, USP, label and affected lot numbers with Expiration Dates and NDC number can be found in the table below. Product was distributed Nationwide from October 11, 2023, to April 11, 2024.
| Product | Lot Number | NDC | Expiration Date | Strength |
| DOCETAXEL INJECTION, USP | F1030001 | 25021-254-16 | 12/2024 | 160mg/16mL (10mg/mL) |
| F1040001 | 25021-254-08 | 12/2024 | 80mg/8mL (10mg/mL) |
